Satellites
to be Built & Launched by 2022 World Market Survey
The 16th edition of this
landmark study. The only analysis & forecast of satellite manufacturing
& launch services
Satellites to be Built & Lunched by
2022, World Market Survey is required reading for anyone interested in the
business generated by satellite systems and their launches. The report is fully
updated, providing all the key figures and analysis needed to understand the
global space market, and the future opportunities & challenges.
Key trends, drivers &
forecasts
- Exclusive 10-year forecasts including breakdown by customer & by orbit, with number & mass of satellites to be manufactured & launched, plus market value (manufacturing & launch services)
- Review of strategic issues from both supply (industry) & demand (customers) perspectives
- Detailed demand database for commercial (order book) and government satellites (forecasts) including: application, launch date, launch mass, satellite platform, manufacturer, launch provider
To check out the complete table of
contents, visit: http://www.marketresearchreports.biz/analysis-details/satellites-to-be-built-and-launched-by-2022-world-market-survey
Who will benefit from this
report?
- Satellite & launch vehicle integrators
- Satellite & launch vehicle parts manufacturers
- Launch & service providers
- Banks, investors & insurers
- Satellite operators
- Space & other government agencies
TABLE OF CONTENT
1 STRATEGIC ISSUES AND
FORECAST
TRENDS IN SATELLITE
MANUFACTURING AND LAUNCH SERVICES
- Three metrics for the space industry in past decade
- 89 satellites launched in 2012 for a market value of $23 billion
- Uncertainty in launch tempo, a fact of the industry
- Strong growth in government satellite demand boosted by 15 countries
- Demand for commercial satellites driven by capacity replacement, both in GEO and LEO
- 42% growth in number of satellites to be launched vs. past decade
- Mass to orbit due to increase by 31% between the two decades
- Industry revenues to grow by 26% in the decade
- Half of the satellites in LEO, 44% of the revenues from GEO
MARKET DRIVERS FOR FUTURE
SATELLITE DEMAND
Satellite systems upstream,
satellite services downstream in the value chain
- Three orbits for three types of customers
- Government and commercial satellites supplied by the same industry
- Three value chain in commercial satellite services
- Growing uncertainty on future satellite demand in the long term
Satellite demand and
satellite industry driven by innovation
- The always better capex efficiency of GEO satellites because of technology advances
- The role of electric propulsion in capex efficiency
- Mission requirements for government satellites in LEO are diverse
- Financing modes of satellite systems diversify
Technical risks and
mitigation solutions also part of the economic equation
- Different strategies for in-orbit risk coverage
- More differentiation in launch insurance price
- The economic impact of space debris starts to be felt
2 COMPETITIVE ENVIRONMENT
& PERFORMANCE OF MARKET PLAYERS
THE SPACE INDUSTRY GLOBALLY
THE SATELLITE MANUFACTURING
INDUSTRY
Consolidation &
vertical integration in the supply chain
- A limited number of experienced satellite integrators
- Trends in financial performance of the satellite manufacturing industry
- 2012 revenue of the satellite industry slightly decreased
- Profitability of the satellite manufacturing industry below 10%
- 29% revenue growth of the manufacturing industry
The GEO comsat industry
- Six incumbent manufacturers of commercial GEO comsat
- New manufacturers of GEO comsat
- Incumbent manufacturers hold 90% of the commercial GEO comsat market
- Manufacturers’ position for new generation GEO satellite systems
The non-GEO satellite
industry
- LEO/MEO satellite manufacturing in North America and Europe
- LEO manufacturing develops outside of Europe and North America
- Commercial comsat constellations now being deployed
- Manufacturing of Earth observation satellites internationalizing
- New initiatives emerging for commercial Earth observation in the USA
Strategic trends impacting
the satellite manufacturing industry
- Opportunistic partnerships between manufacturers for market access
- Competition between manufacturers, not just in technology terms
- PPP & hosted payload for government investment in satellite capabilities
- Delivering one-stop-shop satellite services to governments
- Short-term impact of external factors on western satellite industry
Profiles of 8 satellite
manufacturers
Astrium, Boeing, Lockheed Martin,
Mitsubishi Electric, OHB, OSC, SSL, Thales Alenia Space
THE LAUNCH SERVICE INDUSTRY
Structure of the space
transportation industry
- Existing launch capacity, the result of government demand
- Launch price reflecting the quality of launch service
- 2012 revenues of the launch industry
The GEO launch industry
- The GEO launch industry
- Geostationary orbit by far the largest launch market
- Market shares on the commercial launch market
- Key issues for launch service providers in GTO
The LEO launch industry
- Launch into LEO driven by government satellites
- More vehicles available to launch into LEO higher prices
- More competition to Russian launch vehicles
- Capacity growth under study or under development
Profiles of 4 launch
service providers
Arianespace, ILS, Sea Launch, SpaceX
3 COMMERCIAL SATELLITE
DEMAND
DEMAND CONTEXT FOR
COMMERCIAL SATELLITES
- Four growth drivers for commercial satellite applications
- Scalability of the investment in satellite infrastructure
ASSUMPTIONS FOR COMMERCIAL
SATELLITE DEMAND
- Number of satellites to be launched
- Satellite launch mass
- Specific prices ($ per kg)
THE COMMERCIAL MARKET BY
ORBIT
- Commercial satellites mainly in geostationary orbit
- End of 4th demand cycle of the commercial GEO comsat industry
- Replacement and expansion of in-orbit capacity drive satellite demand
- Cyclicality will soften with a stable order rate at over 20 satellites/year
- HTS for broadband communications not only with dedicated satellites
- Future demand for commercial GEO comsat driven by a double trade-off
- Several factors in the economic equation of increasingly productive satellites
- Growth stopped in satellite lifetime, not in bandwidth capacity
- Satellite power and launch mass still growing but at a slower pace
- Trade-off between concentration of operators and new entrants
- Highly elliptical orbit (HEO) not a commercial orbit anymore
- Medium earth orbit (MEO) now a commercial orbit with O3B
- Low Earth orbit (LEO) populated by the 2nd generation of three comsat constellations and by Earth observation satellites
- All three 1st generation comsat constellations replaced
- Earth observation at less than 10% of commercial space
- DigitalGlobeand Astrium leading data sales
- Two-thirds of commercial data for defense purposes
4 GOVERNMENT SATELLITE
DEMAND
ASSUMPTIONS FOR GOVERNMENT
DEMAND
- Number of satellites to be launched
- Satellite launch mass
- Specific prices ($ per kg)
THE GOVERNMENT MARKET
Market hierarchy between
customers, applications, and regions
- Growth in government demand will be driven by civilian satellites
- Earth observation dominant, both for civilian and military satellites
- Asia dominates for civilian government satellites and catches up for military satellites
- Emerging space countries at over 5% of market value
- Satellite manufacturing at 80% of government market value
Market dynamics by orbit
- LEO by far the largest government satellite market, equally divided between civilian and military agencies
- Demand for earth observation in Low Earth Orbit has multiple forms
- Non-iMINTmissions in LEO driven by military requirements
- AIS, an emerging satcom application in LEO
- Governments innovate to maximize the benefits of LEO satellite systems
- Small satellites in both established and emergent space countries
- Government demand for GEO satellites will grow to over 120 units
- GEO demand driven by civilian government agencies
- Three quasi-zenith satellite systems for national navigation in Asia
- Military satellites in geo predominantly for satcom services
- Military use of geostationary orbit diversifies
- MEO/HEO satellites historically in the USA and Russia, now in china
- More satellites in MEO with the replacement of GPS and Glonass plus two new constellations
- Deep space missions for space science and exploration
5 SATELLITES BACKLOG &
FORECAST
TWO DATABASES EXCLUSIVE TO
EUROCONSULT
Backlog of commercial
satellites under construction, 2013-2016
It is a complement to the market forecast established by Euroconsult on the
number and types of commercial satellites to be manufactured for launch by
2022.
Euroconsult’s forecast of
government satellites, 2013-2022, to be
launched worldwide, including the nominative satellites (under construction as
of January 2013), and those that are planned to be launched by 2022 as a
follow-on to existing systems or as news systems.
Latest
Reports:
Apoptosis Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/apoptosis-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Apoptosis is a programmed natural
process of cell death in the body which results from natural stimuli in order
to protect against viral infection, unusual cell division and cells with
damaged genetic material. However malfunctioning of apoptosis can trigger
uncontrolled and non regulated cell death related to degenerative disorders
such as Parkinson’s disease and Alzheimer’s. Defective apoptosis process has
been one of the most common and leading causes for cancer wherein the affected
cells instead of undergoing apoptosis continue to proliferate and mutate. Thus
development of apoptosis modulating drugs has recently been witnessing
spectacular growth in the treatment for cancer, CNS diseases, and chronic
inflammation or autoimmunity disorders.
The global apoptosis market
is categorized by:
Drug class and consumables
- Direct apoptogens
- First generation indirect apoptogens
- Second generation indirect apoptogens
- Reagents and kits
Indications
- Cancer
- Cardiovascular
- Neurodegenerative diseases
Currently, North America dominates the
global apoptosis market and is followed by Europe due to existence of huge
potential for apoptosis modulating therapeutics and rising popularity of
targeted cancer therapy. Emerging economies of Asia-Pacific, Latin America,
Middle East and Africa are also expected to undergo rapid growth in the
apoptosis market due to the rising incidences of cancer and unmet treatment
needs in such developing regions.
Biological
Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biological drugs are biological medical
products whose active drug substance is extracted by using living organism. The
active substance is derived from living organism by the usage of recombinant
DNA technology. These drugs offer better treatment solutions than synthetic
drugs owing to greater accuracy and fewer side effects. Biological drugs are
mainly made of monoclonal antibodies (mAbs) that help to fight with the
disease. Monoclonal antibodies have the capability of targeting specific area
in the body that requires drug treatment hence producing accurate results.
Majorly biologic drugs are given for the treatment of diseases such as
HIV/AIDS, Alzheimer’s diseases, cancers and others. Moreover, biologic drugs
are also expected to find a solution for the large portion of retired
population which is more prone to chronic diseases.
Global biological drugs market is
growing at substantial rate owing to the drug accuracy and increase in chronic
diseases. In addition, biologic drugs have shown a better outcome in long term
and offer a better quality of life. There are approximately 150 biologic drugs
commercially available in the markets which are being used to treat diseases
such as asthma, irritable bowel syndrome, rheumatoid arthritis, cancer and
others. For example, Avastin for the treatment of lung cancer and Cerezyme for
Gaucher disease are commercially available and cost about USD 100,000 and USD
300,000 per year respectively. However, half of the biological drugs are about
to lose their patent protection and as a result cheaper alternative biogeneric
products are expected to enter in to the market. On the contrary, cost of the
biologic drugs is one the major restraining factor for the growth of this
market. Biologic drugs are costly as compared to other drugs but are likely to
become cheaper in near future. Owing to the potential benefits of the biologic
drugs they have been put on fast track FDA approval process.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
About
Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and
money for our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Blog:
http://industry-research-reports.blogspot.com/
No comments:
Post a Comment